Oxford Centre for Haematology
The OCH Management Board has as members the Director of the OCH, the Head of Clinical Haematology, the Head of Laboratory Haematology, the Head of the Radcliffe Department of Medicine, the Head of the Nuffield Division of Clinical Laboratory Sciences, the Director of the MRC Molecular Haematology Unit, the Director of the MRC Human Immunology Unit, the RDM Research Strategy Coordinator and the Administrator of the OCH.
Single-cell profiling of human bone marrow progenitors reveals mechanisms of failing erythropoiesis in Diamond-Blackfan anemia
Iskander D. et al, (2021), Science Translational Medicine, 13
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19
Kreuzberger N. et al, (2021), Cochrane Database of Systematic Reviews, 2021
Methodological challenges for living systematic reviews conducted during the COVID-19 pandemic: a concept paper
Iannizzi C. et al, (2021), Journal of Clinical Epidemiology
Transitions in lineage specification and gene regulatory networks in hematopoietic stem/progenitor cells over human development
Roy A. et al, (2021), Cell Reports, 36, 109698 - 109698
Under-recognised burden of postoperative anaemia in patients undergoing emergency abdominal surgery in the UK
Kanga K. et al, (2021), British Journal of Anaesthesia, 127, e105 - e108
16 September 2021
A new paper published this week in Cell Reports reveals that changes in the gene expression of blood stem cells occur across the human lifetime; an important step in the understanding and treatment of blood disorders.
10 September 2021
We are delighted to announce that 11 RDM researchers have been awarded the Associate Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Medical Sciences Division.
28 June 2021: Oxford Centre for Haematology Annual Meeting
Please email for further information